1. Long noncoding RNA ANRIL alleviates hypoxia‐induced pulmonary microvascular endothelial cell damage
   Yijin Qi et al, 2024, European Journal of Clinical Investigation CrossRef
2. Role of Long Non-Coding RNA Polymorphisms in Cancer Chemotherapeutic Response
   Zheng Zhang et al, 2021, Journal of Personalized Medicine CrossRef
3. Advances in the application of Let‑7 microRNAs in the diagnosis, treatment and prognosis of leukemia (Review)
   Hao Chen et al, 2021, Oncology Letters CrossRef
4. A Novel miR-98 Negatively Regulates the Resistance of Endometrial Cancer Cells to Paclitaxel by Suppressing ABCC10/MRP-7
   Wei Huang et al, 2021, Frontiers in Oncology CrossRef
5. MicroRNA-98: the multifaceted regulator in human cancer progression and therapy
   Vajihe Hazari et al, 2024, Cancer Cell International CrossRef
6. SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine
   Zu-Wei Wang et al, 2022, Cell Reports CrossRef
7. Long noncoding RNA ANRIL up‐regulates CCND1 via sponging miR‐98‐5p to promote TGF‐β1‐induced human airway smooth muscle cell proliferation, migration, and extracellular matrix deposition
   Zhao‐Gang Zhong et al, 2022, The Kaohsiung Journal of Medical Sciences CrossRef
8. The Long Non-Coding RNA ANRIL in Cancers
   Aymeric Sanchez et al, 2023, Cancers CrossRef
9. Long Non-Coding RNA ANRIL as a Potential Biomarker of Chemosensitivity and Clinical Outcomes in Osteosarcoma
   Adam M. Lee et al, 2021, International Journal of Molecular Sciences CrossRef